Charting Biosimilars In Korea
This article was originally published in PharmAsia News
Executive Summary
Korean pharma firms led by Celltrion are speeding up development of biosimilars, using financial and administrative programs designed by the government to crack markets abroad. PharmAsia News updates the state of play among the leaders.